Mamon HJ - Search Results

1

The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation.

Schoenfeld JD, Wo JY, Mamon HJ, Kwak EL, Mullen JT, Enzinger PZ, Blaskowsky LS, Ryan DP, Hong TS. Schoenfeld JD, et al. Among authors: mamon hj. Am J Clin Oncol. 2016 Jun;39(3):243-7. doi: 10.1097/COC.0000000000000047. Am J Clin Oncol. 2016. PMID: 24577163

2

High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.

Mamon HJ, Yeap BY, Jänne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R. Mamon HJ, et al. J Clin Oncol. 2005 Mar 1;23(7):1530-7. doi: 10.1200/JCO.2005.04.123. J Clin Oncol. 2005. PMID: 15735128

3

Sphincter preservation therapy for rectal cancer.

Aitken C, Breen E, Mamon HJ. Aitken C, et al. Among authors: mamon hj. Clin Adv Hematol Oncol. 2003 Dec;1(12):735-40. Clin Adv Hematol Oncol. 2003. PMID: 16258478 Review.

4

Considerations in treatment planning for esophageal cancer.

Hong TS, Crowley EM, Killoran J, Mamon HJ. Hong TS, et al. Among authors: mamon hj. Semin Radiat Oncol. 2007 Jan;17(1):53-61. doi: 10.1016/j.semradonc.2006.09.001. Semin Radiat Oncol. 2007. PMID: 17185198

5

Adjuvant treatment of colorectal cancer.

Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Wolpin BM, et al. Among authors: mamon hj. CA Cancer J Clin. 2007 May-Jun;57(3):168-85. doi: 10.3322/canjclin.57.3.168. CA Cancer J Clin. 2007. PMID: 17507442 Free article. Review.

6

Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment.

Kozak KR, Kachnic LA, Adams J, Crowley EM, Alexander BM, Mamon HJ, Fernandez-Del Castillo C, Ryan DP, DeLaney TF, Hong TS. Kozak KR, et al. Among authors: mamon hj. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1557-66. doi: 10.1016/j.ijrobp.2007.02.056. Epub 2007 Jun 4. Int J Radiat Oncol Biol Phys. 2007. PMID: 17544599

7

FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results.

Mamede M, Abreu-E-Lima P, Oliva MR, Nosé V, Mamon H, Gerbaudo VH. Mamede M, et al. Am J Clin Oncol. 2007 Aug;30(4):377-88. doi: 10.1097/COC.0b013e31803993f8. Am J Clin Oncol. 2007. PMID: 17762438

8

Is radiation therapy required for patients with intermediate-risk rectal cancer?

Mamon H, Willett CG. Mamon H, et al. Clin Adv Hematol Oncol. 2007 Aug;5(8):638-44, 585. Clin Adv Hematol Oncol. 2007. PMID: 17982404 Review.

9

Sign of Leser-Trélat in newly diagnosed advanced gastric adenocarcinoma.

Nanda A, Mamon HJ, Fuchs CS. Nanda A, et al. Among authors: mamon hj. J Clin Oncol. 2008 Oct 20;26(30):4992-3. doi: 10.1200/JCO.2008.17.9143. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809604 No abstract available.

10

Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.

Hong TS, Killoran JH, Mamede M, Mamon HJ. Hong TS, et al. Among authors: mamon hj. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1612-8. doi: 10.1016/j.ijrobp.2008.07.061. Int J Radiat Oncol Biol Phys. 2008. PMID: 19028285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page